Total Payments
$389.46
2024 Payments
$35.25
Companies
9
Transactions
26
Medicare Patients
936
Medicare Billing
$78,411
Payment Breakdown by Category
Food & Beverage$389.46 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $389.46 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $94.43 | 8 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $75.61 | 4 | $0 (2020) |
| GlaxoSmithKline, LLC. | $52.04 | 4 | $0 (2019) |
| ABBVIE INC. | $42.89 | 2 | $0 (2022) |
| PFIZER INC. | $36.84 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $27.53 | 2 | $0 (2018) |
| Pacira Pharmaceuticals Incorporated | $24.87 | 1 | $0 (2023) |
| DJO, LLC | $19.30 | 1 | $0 (2024) |
| SPR Therapeutics, Inc | $15.95 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.25 | 2 | DJO, LLC ($19.30) |
| 2023 | $24.87 | 1 | Pacira Pharmaceuticals Incorporated ($24.87) |
| 2022 | $15.32 | 1 | ABBVIE INC. ($15.32) |
| 2021 | $41.57 | 2 | AbbVie Inc. ($27.57) |
| 2020 | $66.57 | 4 | Alexion Pharmaceuticals, Inc. ($55.43) |
| 2019 | $108.99 | 9 | GlaxoSmithKline, LLC. ($52.04) |
| 2018 | $76.71 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($49.18) |
| 2017 | $20.18 | 1 | Alexion Pharmaceuticals, Inc. ($20.18) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: Pain management | ||||||
| 06/07/2024 | DJO, LLC | CMF (Device) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Osteogenesis Stimulators | ||||||
| 10/30/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Pain Management | ||||||
| 04/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/24/2020 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Endocrinology | ||||||
| 02/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: DIABETES | ||||||
| 02/05/2020 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Endocrinology | ||||||
| 02/05/2020 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Endocrinology | ||||||
| 11/27/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: DIABETES | ||||||
| 08/09/2019 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: VACCINES | ||||||
| 07/24/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: DIABETES | ||||||
| 04/24/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: DIABETES | ||||||
| 11/14/2018 | AstraZeneca Pharmaceuticals LP | SYNAGIS (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Respiratory | ||||||
| 08/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.99 | General |
| 08/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: DIABETES | ||||||
| 07/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: DIABETES | ||||||
| 04/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: DIABETES | ||||||
| 01/29/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 473 | 1,401 | $115,813 | $37,601 |
| 2022 | 14 | 445 | 975 | $109,662 | $39,361 |
| 2021 | 1 | 18 | 21 | $3,456 | $1,449 |
Total Patients
936
Total Services
2,397
Medicare Billing
$78,411
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 206 | $37,080 | $12,291 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 97 | $24,250 | $7,119 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $9,582 | $5,021 | 52.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 41 | 80 | $14,000 | $3,931 | 28.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 33 | 53 | $11,400 | $3,888 | 34.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $9,680 | $3,123 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $5,780 | $1,668 | 28.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 65 | 638 | $3,828 | $538.32 | 14.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 38 | 227 | $213.20 | $22.01 | 10.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 128 | $32,000 | $10,866 | 34.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 46 | 54 | $18,360 | $6,353 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $8,888 | $5,365 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 82 | $14,760 | $5,086 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $9,360 | $2,941 | 31.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 28 | 55 | $8,820 | $2,728 | 30.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 20 | 33 | $7,410 | $2,335 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $4,840 | $1,386 | 28.6% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 15 | 15 | $870.00 | $852.60 | 98.0% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 15 | 15 | $1,110 | $542.40 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $615.00 | $409.05 | 66.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 43 | 363 | $2,178 | $324.40 | 14.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 17 | $408.00 | $162.40 | 39.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 22 | 108 | $43.20 | $9.81 | 22.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 21 | $3,456 | $1,449 | 41.9% |
About Dr. Blake Averill, MD
Dr. Blake Averill, MD is a Sports Medicine healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1750819165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Blake Averill, MD has received a total of $389.46 in payments from pharmaceutical and medical device companies, with $35.25 received in 2024. These payments were reported across 26 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($389.46).
As a Medicare-enrolled provider, Averill has provided services to 936 Medicare beneficiaries, totaling 2,397 services with total Medicare billing of $78,411. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Greenwood, IN
- Active Since 05/30/2017
- Last Updated 08/05/2025
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1750819165
Products in Payments
- JARDIANCE (Drug) $78.44
- Strensiq (Drug) $55.43
- TRELEGY ELLIPTA (Drug) $41.21
- VRAYLAR (Drug) $27.57
- Exparel (Drug) $24.87
- SOLIRIS (Drug) $20.18
- CMF (Device) $19.30
- SPRINT PNS System (Device) $15.95
- UBRELVY (Drug) $15.32
- SYNAGIS (Biological) $14.98
- ELIQUIS (Drug) $14.00
- FARXIGA (Drug) $12.55
- PREVNAR - 13 (Biological) $11.99
- CHANTIX (Drug) $10.85
- NUCALA (Biological) $10.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Greenwood
Dr. Sean Calloway, M.d, M.D
Sports Medicine — Payments: $129,917
Sports Medicine $129,917
Mark Dilella, Do, DO
Sports Medicine — Payments: $3,945
Sports Medicine $3,945
Dr. Scott Gudeman, Md, MD
Sports Medicine — Payments: $3,281
Sports Medicine $3,281
Dr. Jeffrey Peterson, Md, MD
Sports Medicine — Payments: $2,881
Sports Medicine $2,881
Thurman Alvey, D.o, D.O
Sports Medicine — Payments: $1,010
Sports Medicine $1,010
Philip Blaney, M.d, M.D
Sports Medicine — Payments: $474.71
Sports Medicine $474.71